chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He used Botox after the getting the COVID vaccine and the Botox worked; This spontaneous case was reported by a physician and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (He used Botox after the getting the COVID vaccine and the Botox worked) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product BOTULINUM TOXIN TYPE A (BOTOX) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and BOTULINUM TOXIN TYPE A (BOTOX) (unknown route) UNK 10 units. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (He used Botox after the getting the COVID vaccine and the Botox worked). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (He used Botox after the getting the COVID vaccine and the Botox worked) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment medication information was not provided by the reporter.  Reporter (HCP) to report LOE from Botox for a patient as well as himself. Medication was not confirmed as Botox Cosmetic. He utilized Botox from the same lot number that was used on the patient and he also did not have an effect from the Botox. He used 40 units of the 50 unit Botox vial on the patient and the remaining ten units left from the vial on himself. He also did not have an effect from the Botox. HCP has been using Botox for years, never saw a lack of effect from Botox; it is a coincidence that the patient and the HCP both did not have an effect from the vial. HCP says he is certain it was the Botox vial with that lot number and expiration date that caused the lack of effect; he stated he was very careful and has been using Botox for a long time. When he used Botox he will only used the vial on the same day it was first used. HCP thinks he had asymptomatic COVID because he had COVID antibodies prior to receiving the COVID vaccine. He used Botox after the getting the COVID vaccine and the Botox worked.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
02/21/2023 I woke up with a runny nose and low grade fever I took a home COVID-19 test and tested positive. I reached out to Dr. and was prescribed PAXLOVID I also took OTC MUCINEX and zinc. I was feeling better after 5 days.
Mom called to report irritability since day after vaccines received; temp 99.8 X 2 days; site reported to appear normal; parent declined an appointment to have child seen.  Mom called our office on 5-19-10 to report this.
Immediately after she was given her immunizations she c/o severe headache, got very pale, diaphoretic and light headed.
Patient noticed red bumps around injection site on 5/13/07. The patient is not sure how long the bumps had been there. She received the injection on 5/10/07. Had injection Left deltoid.
A 38 year old female pt developed muscle pain, low grade fever, aches and malaise after receiving RabAvert therapy for prophylactic vaccination. The pt received the first dose of RabAvert 1ml IM on 21May04. Within twenty four hours of receiving the RabAvert, the pt developed local muscle pain, low grade fever (99.9F), general aches and malaise. On 25May04, the pt noticed that her supraclavicular lymph nodes were tender, swollen and enlarged 2-3cm in size. No additional information was available at the time of the report. Follow up received 22Jun04: The pt's date of birth was 21Feb04. Events began approx twenty four hours after receiving the second dose. Lymphadenopathy Subclavicular on the same side (left ) of the last injection was noted. Several other lymph nodes were noted and enlarged in the same general area and all were tender. The event subsided over a few weeks. The pt did not received the third and final dose in the series. Lot numbers nor expiration dates were provided.
Tested positive for COVID-19 in July2021; Tested positive for COVID-19 in July2021; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on May2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 13Jul2021 the patient tested positive for covid-19 in July2021. COVID test type post vaccination: PCR (nasal swab): positive. No treatment was received for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the event was recovering.   lot/batch number and expiration date not reported
Pt rec'd imm 3/1/05 did not have any problems. Then on 3/14/05, pt was taken to family doctor for eye infection. He was prescribed Cephalexin and some sulfa eye gtts. He had a low grade temp 100.8 and was also on Tylenol for this. Pt received antibiotic, eye gtts 2 x on 3/14 and 3x on 3/15/05. After 9:15PM dose of meds on 3/15/05, pt went to sleep. He awoke at 9:45PM screaming uncontrollably for about 30 mins and his eyes rolled back. Pt was taken to the ER and subsequently admitted to hosp for overnight observation. By the time pt arrived at ER he had settled down and had no more episodes of screaming. Ct scan of head and CXR were done on 3/15/05. CT showed no acute intracranial abnormality identified, abnormal soft tissue of nasopharynx and opacification of the maxillary sinuses. CXR showed mild perihilar infiltrates are questioned on the lateral projection. Pt was dismissed from hospital 3/16/05 and continued Cephalexia but not the sulfa eye gtts. GM states that pt is doing well now just has nasal congestion. Pt has appt 3/23/05 with family doctor at which time a referral will be made to hospital for eval. Information from Discharge summary states corneal lesion, groggy. msv
Incorrect administration of an immunization authorized as a booster for patients over 18. Patient is 16 yrs old. The day after he is experiencing low grade fever.
Presented to ER with mom reporting increased temperature early morning and seizure-like activity X about 15 minutes. Upon arrival to ER, temperature of 101.7F (ax). ERP had staff call HD after family reported immunization on 1/23/02. The child was admitted with a dx of febrile seizure and LLL pneumonia. She is still hospitalized. *F/UP on 3/31/03: PT had another seizure 3/2 and was taken to hospital - reporter thought child had fever. 3/3 - child taken to a medical center w/fever and kidney infections having seizures. Had several while in hospital. Child went 3/24/02 to another hospital for more test r/t seizures - don't have results yet. Follow up states: Pt had another episode of seizure in May. Mom states pt had ear infection and that ER doctor r/t fever. Pt stayed overnight at hospital.
a patient accidentally received a dose of MENQUADFI on 18Oct2023, and then he received another dose of MENQUADFI on 25Oct2023 with no reported adverse event; Initial information received on 26-Oct-2023 regarding an unsolicited valid  non-serious case received from a nurse.  This case involves a 17 years old male patient who accidentally received a dose of Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] on 18oct2023, and then he received another dose of menquadfi on 25oct2023 with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 18-Oct-2023, the patient received 0.5 ml (Dose 1) of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine Solution for injection (lot number: U7673AA) (Expiry date: 29-Jun-2025) (Strength: standard) (Frequency: once) via intramuscular route in unknown administration site for prophylactic vaccination (Immunisation). On 25-Oct-2023 he also received a Dose 2 of the same vaccine of same batch and expiry date via intramuscular route in the left arm for prophylactic vaccination (Immunisation).  On 25-Oct-2023, the patient accidentally received a dose of Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] on 18oct2023, and then he received another dose of menquadfi on 25oct2023 with no reported adverse event (extra dose administered) (latency: 7 days).  It was reported, Nurse reports that there was a medication error where a patient accidentally received a dose of MENQUADFI on 18Oct2023, and then he received another dose of MENQUADFI on 25Oct2023. She asks for information that they can provide to the patient's parents. This situation is reported as a medication error due to patient received 2-MENQUADFI doses 1-week apart. The nurse explains that they did a vaccine clinic at school; there was a language barrier between the staff and the patient's parents. The patient's parents signed the patient up for the vaccine clinic on 13Oct2023. The staff pulled the patient's vaccination records on 13Oct2023, and at that time the patient did not have a second dose of meningococcal vaccine. The nurse explains that in the time between when they signed up for the vaccine clinic on 13Oct2023 and the vaccine clinic event on 25Oct2023, the patient had gone to his PCP or the health department and received a dose of MENQUADFI on 18Oct2023. He then received another dose of MENQUADFI at the vaccine clinic on 25Oct2023. They only caught the error when they were entering the MENQUADFI dose into the vaccine record system.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
8 hrs p/shot, chills & sweats body ache; temp 100/2 11SEP93 had ER visit, coughing;
Received flu shot Monday 9/30/13, that night had chills, next morning 10/1/13, woke up  with hives on face (one behind ear and 2 on chin), felt itchy all over and tingling felt in lips mostly bottom lip left side. Took Benadryl tablet, kept symptoms at bay for around 6 hrs, took another Benadryl 7 PM on 10/1 and again 9 AM 10/2 and 10 PM on 10/2.
pt recv vax & exp soreness & heat @ the inj site;devel redness @ the inj site, & exp muscle aches to point where could not lift arms;
Uncomfortable chest pain. Intense pressure left upper body. Started feeling pain about 14-15 hours after I got the booster shot. Still have uncomfortable pain after 2 days.
Patient suffered a Heart Attack 13 days after receiving his second covid vaccine. The heart attack was unknown and presented as the flu at the time.  9 days later he had a second event that finally drove him to the hospital. A bout 3 days after entering the hospital he suffered a dual hemispherical stroke.   NOTE: this report is being filed by me as POA as requested by his family.
Redness, extreme swelling, soreness, fever of 100. Redness, swelling and fever lasted five days. Then horrible shoulder pain started and continued to get worse. I finally went to my rheumatologist on 4-12-10 because the pain was unbearable. I told him I thought it was the pneumococcal vaccine that caused the pain. My rotator cuff is so inflamed that, now, 10 months later, I still have extreme pain and have lost a lot of strength in my left arm. Even putting on a shirt is extremely painful. I cannot lift a gallon of milk higher than my thighs without cringing in pain. I feel partially disabled now and am wondering if the pain will ever resolve and if I will ever get full use of my left arm back.
Patient received expired dose after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose after manufacturer date of expiry) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  It was reported that the vial was stored in the refrigerator on 05-Mar-2022. Vial did not undergo any temperature excursions.  Treatment information was not provided by the reporter.   This case was linked to MOD-2022-532744, MOD-2022-532663, MOD-2022-532745 (Patient Link).
Dizziness, vertigo, and foggy head.  I was grocery shopping when I felt dizzy looking for items in the store.  I felt sick and had to return to the car and drive home. The symptoms continue days later.
Syncopal episode 2 minutes after immunizations.  Fell to floor. B/P 98/64; Pulse 83; Oxygen sat 98%.  Legs elevated.  Recovered without incident; denies pain.
Patient has issues with finger movement of the left hand, sometimes stiff arm and pain,  The inside of the palm is slightly swollen. Patient did not report the issue until after the second shot.  Patient said daily duration of the daily  problem has become less  but  the arm is stiff during the day and she has to push on finger up sometimes.
Child developed hives all over body appox 3 minutes post vaccine. Epi 0.3 given IM at 10:45 AM 911 called 10:46 AM Pt transported to hospital. No resp distress present.
12/19/2020 I received COVID19 Pfizer-BioNTech EJ1685 and about 8 hours later became extremely dizzy but did not have true vertigo. I held on to furniture and crawled to bed. 6 hours later when I awoke the symptoms were completely gone.  09/20/2021 21 At 21 days  and 12 hours after receiving COVID19 Pfizer-BioNTech FF2588 inoculation, I awoke with numbness on my right side both upper and lower extremities and my face, had dysarthria, and right sided partial ataxia. This improved rapidly to the point that I could walk to the ambulance and could speak clearly within a manner of minutes. Complete resolution of the numbness took probably 4 hours with my lower extremity distally being the last area of resolution. The dysarthria was completely resolved by the time I arrived at the emergency room. which is less than 1 mile from my house.
We had someone walk-in for a booster dose of Moderna today. The patient had their immunization card which showed their first and second doses in March of 2021. After administration the patient reported to us, that they had a 3rd dose prior to today and they planned on receiving a "booster" every 3 months. We then checked state shots records and confirmed they had in fact received a 3rd dose of Moderna back in August of 2021. The patient did not have a record of the third dose on their vaccine card or admit to having it until we had already administered another dose again today.
I am an  OB/ GYN Physician. 8 days post Moderna bivalent vaccine I developed a severe  DELAYED HYPERSENSITIVITY REACTION  proven by skin biopsy and referenced to  Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.  2022 Jan; 49 (1):34-41.PMID; 34292611  with severe pruritic rash covering all extremities. I required extremely HIGH STEROID dose 60 mg/day ( I weigh 126 lb) for 12 days to control symptoms, now on taper.  after 4 weeks rash is starting to resolve.
Administration error. 15y/o inadvertently given Pfizer vaccine at a mass-vaccination event. Tolerated well with no side effects or reactions.
Patient was here to receive several vaccine boosters --  Tdap, MCV4 and HPV (#1)  Patient had not eaten any breakfast before coming to appointment.  Patient was nervous and we used the Pain Ease numbing spray to numb her arm for the first 2 vaccines (Tdap and MCV4) given in the Left arm,  Patient did fine with first 2 vaccines.  Right arm was prepped and  HPV was administered, patient started to faint within about 5 seconds after the administration.  Patient was sitting upright on the exam table and with the mothers help was lowered to a flat position.  Provider was immediately called back into the exam room.  Patient came out of spell within 60 seconds and was given Apple juice and Graham crackers.  Her color came back within a few minutes and she stated she felt better.  The provider evaluated her condition to be stable.   The nurse (myself) remained with the patient for an additional 10-15 min after her spell to ensure her stability before she left the Peds dept.
This spontaneous report as receive from a nurse concerning a 5-year-old patient of unknown gender. No concurrent conditions or medical history were provided. On an unknown date, the patient was vaccinated with a dose of VARIVAX (Merck) and a dose of PROQUAD (Merck) (strength, dose, route of administration, lot# and expiry date were unspecified for both) instead of M-M-R II as prescribed at the office visit. No concomitant medications were reported. No adverse effects were reported. Follow up information was received on 30-MAR-2015 from a nurse refers to a female patient. On 27-JAN-2015, the patient was vaccinated with the first dose of PROQUAD (Merck) (lot# reported as: K025798), subcutaneous in the let thigh and the first dose of VARIVAX (Merck) (lot # K11797), subcutaneously in the right thigh. It was unknown if any laboratory test were performed. This is one of several reports from the same source. Additional information is not expected as all required correspondence was scheduled.
Vivid/lucid dreaming with bright lights; Vivid/lucid dreaming with bright lights; light headiness a feeling that i would pass out or die and tingling and shakimg; tingling and shaking throughout his body; tingling and shaking throughout his body; As he remained in a confused mental state; received bnt162b2 first dose on 10Mar2021, second dose on 24Mar2021; received bnt162b2 first dose on 10Mar2021, second dose on 24Mar2021; nocturnal panic attack with unknown trigger; Occasinally elevated blood pressure; slight markings of dehydration; hangover; This is a spontaneous report from a Contactable consumer (patient). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, brand: Pfizer), second dose via an unspecified route of administration, administered in arm left on 24Mar2021 11:30 at age of 40-year-old (Lot Number: ER8733) at single dose for COVID-19 immunization. The most recent COVID-19 vaccine was administered at Facility of Doctor's office/urgent care. Medical history included gout, anxiety, gastrooesophageal reflux disease, 'espoghutis'. The patient did not have allergies to medications, food, or other products. Concomitant medication within 2 weeks of vaccination included omeprazole; allopurinol; escitalopram. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 via an unspecified route of administration, administered in arm left on 10Mar2021 11:30 at age of 40-year-old (Lot Number: En6206) at single dose for COVID-19 immunization. On 02Apr2021, the patient had vivid/lucid dreaming with bright lights and unusual feelings as he initially fell asleep. He was able to wake himself up but remained in between sleep and awake. This was accompanied by light headiness a feeling that he would pass out or die and tingling and shaking throughout his body as he remained in a confused mental state while his wife called an ambulance. In 2021, his vitals were fine with occasionally elevated blood pressure and slight markings of dehydration ( during the day following his second dose he felt like he had a bad hangover). The ER doctor thought the most likely explanation is sometime of nocturnal panic attack with unknown trigger. He had not previously sufferer anything like it. The events were reported as non-serious. The adverse events result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received treatment for the adverse events which included: drugs to calm, fluids. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events light headiness, tingling and shaking throughout his body, confused mental state, nocturnal panic attack with unknown trigger, vivid/lucid dreaming with bright lights, elevated blood pressure, slight markings of dehydration, hangover were resolving.   Information on lot/batch number obtained. Further information is expected.
Ophthalmic rash, vesicles, fever X 2days 2/3/09 - given vaccine 1/27/09
Arthritic/Gout type attack 2nd day after the first dose 1/25/21 and the second day after the second  dose 2/15/21. First attack was right wrist. Second attack was right ankle
Child was given DTAP in Lt arm on 9/28/09 came back to office on 9/29/09 upper arm red and swollen.
Employee called stating that she received her second dose Pfizer vaccine on 7/26/2021. She woke up this morning not feeling well. Stated her right arm where she received the vaccine is very sore and she can barely lift it. Also stated that her whole body is achy, and she has pressure in her head. Employee stated that she took 600mg of Ibuprofen this morning at 5am. Stated after taking the Ibuprofen her body aches seem to be improving. Informed employee to continue taking Ibuprofen per label instructions as needed, and if symptoms do not improve, worsen, or if new symptoms develop to call us back.
Information was received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 10-DEC-2009, the patient was inoculated at a physician's office with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 02-FEB-2013, the patient was treated by a Physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles with complications. The patient was prescribed valacyclovir (VALTREX) and tramadol for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Patient is a volunteer at a vaccine distribution center.  She was able to get a vaccine herself because of this.  She reports a persistent vice-like headache that began the day she received her first dose of vaccine that has persisted.  Her blood pressure went up with this, so she was started on metoprolol which brought her blood pressure down, but did not affect the headaches. Patient received her 2nd dose of the Pfizer vaccine on 2/27/21 and reports that in addition to the headache she feels fatigued and reports excessive thirst.  She is still be worked up for the headaches.
Fever,  malaise, body aches, fatigue, cognitive impairment, and changes in menstruation.